New movement in Parkinson's

Sci Am. 2005 Jul;293(1):68-75. doi: 10.1038/scientificamerican0705-68.
No abstract available

MeSH terms

  • Aging
  • Antiparkinson Agents / therapeutic use
  • Cell Death
  • Dopamine / biosynthesis
  • Electric Stimulation
  • Glial Cell Line-Derived Neurotrophic Factor
  • Humans
  • Molecular Chaperones / physiology
  • Mutation
  • Nerve Growth Factors / therapeutic use
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurons / metabolism
  • Neurons / pathology
  • Parkinson Disease / genetics*
  • Parkinson Disease / pathology
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy*
  • Proteasome Endopeptidase Complex / physiology
  • Protein Folding
  • Substantia Nigra / pathology
  • Substantia Nigra / physiopathology
  • Synucleins
  • Ubiquitin / physiology
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Antiparkinson Agents
  • GDNF protein, human
  • Glial Cell Line-Derived Neurotrophic Factor
  • Molecular Chaperones
  • Nerve Growth Factors
  • Nerve Tissue Proteins
  • Synucleins
  • Ubiquitin
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Proteasome Endopeptidase Complex
  • Dopamine